{
    "code": "06019599",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=06019599",
    "time": "2020-02-25 19:48:53",
    "許可證字號": "衛署醫器輸字第019599號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "QSD4639",
    "有效日期": "112\/11\/25",
    "發證日期": "97\/11\/25",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "通關簽審文件編號": "DHA00601959901",
    "中文品名": "亞培設計師賽若莫司檢驗試劑組",
    "英文品名": "ABBOTT ARCHITECT Sirolimus",
    "效能": "ARCHITECT Sirolimus 分析是一種化學冷光微粒免疫分析法 (Chemiluminescent Microparticle Immunoassay ; CMIA)，可用於ARCHITECT i 系統上定量測試人類全血中的藥物sirolimus。ARCHITECT Sirolimus分析可用於輔助管理接受sirolimus治療之腎臟移植病患。",
    "醫器規格": "1L76-25 ARCHITECT Sirolimus Reagent Kit, 100 Tests; 1L76-01 ARCHITECT Sirolimus Calibrators; 1L76-55 ARCHITECT Sirolimus Whole Blood Precipitation Regent。註銷規格：1L76-55。",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "A臨床化學及臨床毒理學",
    "醫器次類別一": "A1150校正品",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "0932301100  美商亞培股份有限公司台灣分公司",
    "申請商地址": "台北市中山區民生東路三段49號5樓、6樓及51號6樓",
    "主製造廠": [
        {
            "製造廠名稱": "MUS1165000  FUJIREBIO DIAGNOSTICS, INC.",
            "製造廠廠址": "201 GREAT VALLEY PARKWAY MALVERN, PA 19355, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "06019599註銷規格___20130418.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06019599&Seq=002&Type=9"
        },
        {
            "title": "060195990001-103-06-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06019599&Seq=001&Type=8"
        }
    ]
}